Form 4: Journey Medical Corp CFO Sells Shares to Cover Tax Obligations

Journey Medical Corp's CFO, Joseph Benesch, sold 2,409 shares of common stock on May 2, 2025, to cover tax obligations related to vesting restricted stock units.

Summary

• On May 2, 2025, Joseph Benesch, CFO of Journey Medical Corp, sold 2,409 shares of the company's common stock.
• The sale was executed at a weighted average price of $6.84 per share.
• The shares were sold to satisfy tax withholding obligations related to the vesting of restricted stock units.
• Following the transaction, Benesch directly owns 203,557 shares, including restricted stock units that vest over time.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale for tax obligations) by a company insider, which is neither particularly positive nor negative.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This sale appears to be related to tax obligations, which is a common occurrence when restricted stock units vest.

Stakeholder Impact

• The sale of shares by the CFO could have a minor, temporary impact on the stock price, but is unlikely to be significant given the relatively small number of shares involved.

Key Dates

Keywords

Journey Medical Corp, DERM, Joseph Benesch, CFO, stock sale, Form 4, restricted stock units, tax withholding, insider trading